ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 629229 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 629229; 2) Community: the network communities that were significantly associated with the response to NSC 629229; 3) Molecule: the relationships between components within communities and NSC 629229; 4) MDR: the compounds that were significantly associated with the NSC 629229.

NSC Compound Enrichment Correlation
NSC 208652 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- 0.0403978426119741 0.00097967074
NSC 208734 ACLACINOMYCIN A 0.0403978426119741 0.33553355
NSC 333054 Adriamycin, tetrahydropyranyl 0.0403978426119741 0.13132021
NSC 34533 Fulcin 0.0403978426119741 0.19801202
NSC 347217 Carbamic acid, [5-amino-1,2-dihydro-3-(2-naphthalenyl)pyrido[3,4-b]pyrazin-7-yl]-, ethyl ester, monohydrochloride 0.0403978426119741 0.066591931
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.0403978426119741 0.21462152
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0403978426119741 0.12684372
NSC 529108 4-Fluoro-D,L-tryptophan 0.0403978426119741 -0.026334054
NSC 603624 Null 0.0403978426119741 0.12530688
NSC 610456 Camptothecin Derivative 0.0403978426119741 0.046123355
Total:97  Current:90    [First] [Prev] [Next] [Last]